DNAPrint Genomics, Inc.
DNAG · OTC
9/30/2007 | 6/30/2007 | 3/31/2007 | 12/31/2006 | |
|---|---|---|---|---|
| Market Cap | $4 | $5 | $5 | $4 |
| - Cash | $0 | $1 | $0 | $1 |
| + Debt | $5 | $6 | $6 | $7 |
| Enterprise Value | $9 | $10 | $10 | $11 |
| Revenue | $0 | $0 | $1 | $1 |
| % Growth | -52.3% | -32% | 33.4% | – |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | -2.9% | 18% | 26.6% | 34.4% |
| EBITDA | -$2 | -$1 | -$1 | -$1 |
| % Margin | -662.2% | -267.8% | -144.7% | -246.6% |
| Net Income | -$2 | -$2 | $3 | -$4 |
| % Margin | -826.7% | -355.8% | 412% | -734.5% |
| EPS Diluted | -0.003 | -0.003 | 0.01 | -0.009 |
| % Growth | 0% | -130% | 211.1% | – |
| Operating Cash Flow | -$1 | -$1 | -$1 | -$0 |
| Capital Expenditures | -$0 | $0 | -$0 | -$0 |
| Free Cash Flow | -$1 | -$1 | -$1 | -$0 |